Trial intelligence / Profile preview

Insulin Detemir in Taiwanese Patients with Type 2 Diabetes

NCT00521690Phase 4Completed

Sponsor
Novo Nordisk
Start
Dec 2006
Primary completion
Aug 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Dec 2006; status: completed.

02

Drugs

insulin detemir
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00521690.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00521690.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call